Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908

Autor: Frasci, G. *, D’Aiuto, G., Comella, P., D’Aiuto, M., Di Bonito, M., Ruffolo, P., Iodice, G., Petrillo, A., Lastoria, S., Oliviero, P., Capasso, I., Montella, M., Siani, C., Santangelo, M., Vizioli, L., Comella, G.
Zdroj: In Annals of Oncology April 2010 21(4):707-716
Databáze: ScienceDirect